These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30658112)

  • 1. Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
    Pourbagheri-Sigaroodi A; Bashash D; Safaroghli-Azar A; Farshi-Paraasghari M; Momeny M; Mansoor FN; Ghaffari SH
    Eur J Pharmacol; 2019 Mar; 846():49-62. PubMed ID: 30658112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
    Bashash D; Zareii M; Safaroghli-Azar A; Omrani MD; Ghaffari SH
    Hematology; 2017 Jul; 22(6):330-340. PubMed ID: 28054503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies.
    Biray Avci C; Dogan F; Ozates Ay NP; Goker Bagca B; Abbaszadeh Z; Gunduz C
    J Cell Biochem; 2018 Dec; 119(12):9817-9824. PubMed ID: 30145821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
    Bashash D; Ghaffari SH; Mirzaee R; Alimoghaddam K; Ghavamzadeh A
    Leuk Lymphoma; 2013 Mar; 54(3):561-8. PubMed ID: 22957790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
    Shi Y; Sun L; Chen G; Zheng D; Li L; Wei W
    Target Oncol; 2015 Dec; 10(4):565-73. PubMed ID: 25916999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway.
    Fatemi A; Safa M; Kazemi A
    Tumour Biol; 2015 Nov; 36(11):8425-37. PubMed ID: 26022158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
    Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.
    Bashash D; Ghaffari SH; Zaker F; Kazerani M; Hezave K; Hassani S; Rostami M; Alimoghaddam K; Ghavamzadeh A
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1115-25. PubMed ID: 23293885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532.
    Liu C; Zhou H; Sheng XB; Liu XH; Chen FH
    Bioorg Chem; 2020 Sep; 102():104077. PubMed ID: 32682156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway.
    Nasrollahzadeh A; Bashash D; Kabuli M; Zandi Z; Kashani B; Zaghal A; Mousavi SA; Ghaffari SH
    Life Sci; 2020 Sep; 257():118060. PubMed ID: 32645343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120.
    Bashash D; Delshad M; Safaroghli-Azar A; Safa M; Momeny M; Ghaffari SH
    Int J Biochem Cell Biol; 2017 Oct; 91(Pt A):1-8. PubMed ID: 28834761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.
    El-Daly H; Kull M; Zimmermann S; Pantic M; Waller CF; Martens UM
    Blood; 2005 Feb; 105(4):1742-9. PubMed ID: 15507522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment.
    Gala K; Jain M; Shah P; Pandey A; Garg M; Khattar E
    Life Sci; 2024 Feb; 339():122416. PubMed ID: 38216120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription.
    Bashash D; Ghaffari SH; Zaker F; Hezave K; Kazerani M; Ghavamzadeh A; Alimoghaddam K; Mosavi SA; Gharehbaghian A; Vossough P
    Cancer Invest; 2012 Jan; 30(1):57-64. PubMed ID: 22236190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-κB and downregulation of Bcl-2, XIAP, and c-Myc.
    Farhadi E; Safa M; Sharifi AM; Bashash D
    Anticancer Drugs; 2017 Jan; 28(1):51-58. PubMed ID: 27548348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
    Kusoglu A; Goker Bagca B; Ozates Ay NP; Gunduz C; Biray Avci C
    Gene; 2020 Oct; 759():145001. PubMed ID: 32738420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
    Mueller S; Hartmann U; Mayer F; Balabanov S; Hartmann JT; Brummendorf TH; Bokemeyer C
    Invest New Drugs; 2007 Dec; 25(6):519-24. PubMed ID: 17534576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce
    Pandya VA; Crerar H; Mitchell JS; Patani R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
    Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
    Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of compound aITEL1296 on telomerase activity and the growth of cancer cells].
    Kovalenko NA; Zhdanov DD; Bibikova MV; Gotovtseva VIu
    Biomed Khim; 2011; 57(5):501-10. PubMed ID: 22629600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.